{
  "anumber": "A28601314",
  "id": "A28601314_0012",
  "page_index": 12,
  "resources": {
    "full_jpg": "https://dctn4zjpwgdwdiiy5odjv7o2se0bqgjb.lambda-url.us-east-1.on.aws/iiif/3/og-2023-kc-nara_A28601314_0012/full/max/0/default.jpg"
  },
  "fields": {
    "sex": {
      "ms_sex_llm_v1": "male"
    },
    "doctype": {
      "ms_doctype_v1": "form"
    },
    "form_title": {
      "ms_form_title_llm_v1": "National Health Laboratories, 05644801-6"
    },
    "years": {
      "ms_years_nlp_v1": [
        2023,
        1987
      ]
    }
  },
  "is_g325a": false,
  "is_cert_naturalization": false,
  "full_text": "Screened by NARA, 6/6/2023 National 1050 NORTH PO JAK, SUITE 145 P.O. BOX 2367 Health HOUSTON, TEXAS 77055 LAFAYETTE, LA 502 PHONE 713-681-8477 800-833-8078 318-234-6366 800-252-3327 Laboratories HHS NO. 42-1037; MEDICARE NO. 45-8267 HHS NO. 19-8008; MEDICARE NO. 000198008 DATE REPORTED DATE RECEIVED PATIENT NAME/ID. ACCESSION NO. 8-Mar-88 8-Mar-88 PENA, AURELIO 0564801-6 ANDRES G. PEDROZA, M.D. CLIENT NO. TEST REQUESTED AGE 3322 CANAL ST 95587-105 FTA-IF, SUITE 103 8-9 HTLV III, SYPHILIS SEROLOGY, 81 NEW ORLEANS, LA 70119 SEX M PHYSICIAN REMARKS REQUISITION NO. H8417145 HEALTH SURVEY* GLUCOSE BUN CREAT URIC A Na+ K+ CI- CO2 T. BILI GGTP SGOT SGPT 65-115 mg/dl 5-25 mg/dl 0.5-1.5 mg/dl M 3.5-8.5 mg/dl 135-145 mEq/L 3.5-5.5 mEq/L 96-109 mEq/L 22-32 mEq/L 0.2-1.5 mg/dl 0-65 IU/L 0-40 IU/L 0-45 10/L F 2.5-7.5 mg/dl LIPID ASSESSMENT* ALK. PHOS LDH T. PROTEIN ALB GLOB A/G Ca++ PHOS CHOL HDL CHOL/HDL TRIG 30-130 10/L 100-225 IU/L 6.0-8.5 g/dl 3.5-5.5 g/dl 1.8-3.2 g/dl 1.3-2.7 8.5-11.0 mg/dl 2.2-4.5 mg/dl RATIO THYROID THERAPEUTIC DRUGS T. IRON GLUCOSE T3 UP T4 (RIA) T7 TSH T3 (RIA) DILANTIN PHENO DIGOXIN THEOPHYL LITHIUM 40-150 mcg/dl PLASMA 25-35% 4.5-12.5 mcg/dl 1.0-4.0 Units 0.6-4.6 u/U/ml 50-170 ng/dl 10-20 mcg/ml 15-40 mcg/ml 0.5-2.0 ng/ml 10-20 mcg/ml 0.5-1.4 mEq/L 65-115 mg/dl CBC* PRENATAL/SEROLOGY WBC RBC HGB HCT MCV MCH MCHC BLOOD Rh ANTIBODY SYPHILIS RUBELLA 3.8-11.0x103 M 4.5-6.1 x 106 M 13.5-18.0 g/dl M 42-54% 80-101 28-33 pg 31-36% GROUP TYPE SCREEN SEROLOGY INDEX F 4.1-5.4 x 106 F 11.5-16.0 g/dl F 37-47% NR DIFFERENTIAL NEUT LYMPH MONO EOS BASO PLATELETS SED RATE PREGNANCY MONO SPOT RA LATEX LE LATEX CRP 40-80% 15-50% 2-11% 1-7% 0-1% 130-450 x 103 M 0-10 mm/hr neg neg neg neg F 0-20 mm/hr URINALYSIS COLOR APPEAR. SP GRAV pH PROTEIN GLUCOSE KETONES BLOOD LEUKOCYTE NITRITE URINE CREATININE yellow clear 1.003-1.035 5.0-8.0 neg neg neg neg ESTERASE neg CREATININE CLEARANCE neg 1-2 g/24 hr. 80-140 ml/min. COMMENTS/OTHER TEST RESULTS: PEDIATRIC & LIPID NORMALS-SEE REVERSE SIDE RESULT NAME RESULT UNITS NORMALS FTA-IF *NOT INDICATED NR HTLV III, SYPHILIS SEROLOGY *** HIV<HTLV-III)-AB (IGG)NEG negative A RESULT OF \"POSITIVE\" INDICATES THE PRESENCE OF ANTIBODY TO THE HIV(HTLV-III) VIRUS, CURRENTLY CONSIDERED THE ETIOLOGIC AGENT FOR THE ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS). THE PRESENCE OF THE ANTIBODY TO HIV (HTLV-III) IS INDICATIVE OF EXPOSURE TO THE VIRUS BUT IS NOT DIAGNOSTIC OF CURRENT ACTIVE INFECTION. POSITIVE RESULTS SHOULD BE CONFIRMED BY A MORE SPECIFIC TEST, E.G. WESTERN BLOT. PLEASE CONTACT THE LAB FOR DETAILS. PAGE 1 END OF REPORT FOR PENA, AURELIO Â© 1987 NATIONAL HEALTH LABORATORIES CHART COPY"
}